Cargando…
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
The field of tumor vaccination is currently undergoing a shift in focus, from individualized tailor-made vaccines to more generally applicable vaccine formulations. Although primarily predicated by financial and logistic considerations, stemming from a growing awareness that clinical development for...
Autores principales: | de Gruijl, Tanja D., van den Eertwegh, Alfons J. M., Pinedo, Herbert M., Scheper, Rik J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491427/ https://www.ncbi.nlm.nih.gov/pubmed/18523771 http://dx.doi.org/10.1007/s00262-008-0536-z |
Ejemplares similares
-
Autologous tumor cell vaccination combined with systemic CpG-B and IFN-α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
por: Koster, Bas D., et al.
Publicado: (2019) -
Dendritic cell vaccination and immune monitoring
por: Aarntzen, E. H. J. G., et al.
Publicado: (2008) -
IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation
por: Lindenberg, Jelle J., et al.
Publicado: (2013) -
Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition
por: Oosterhoff, Dinja, et al.
Publicado: (2012) -
Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells
por: van Dodewaard-de Jong, Joyce M., et al.
Publicado: (2015)